MetaADEDB 2.0 @ LMMD
saxagliptin
(QGJUIPDUBHWZPV-SGTAVMJGSA-N)
Structure
SMILES
N#C[C@@H]1C[C@H]2[C@@H](N1C(=O)[C@H](C13CC4CC(C1)CC(C3)(C4)O)N)C2
Type(s)
Approved
ATC code(s)
A10BD10; A10BD21; A10BD25; A10BH03
Molecular Formula:
C18H25N3O2
Molecular Weight:
315.410
Log P:
1.7962
Hydrogen Bond Acceptor:
5
Hydrogen Bond Donor:
2
TPSA:
90.35
CAS Number(s):
361442-04-8
Synonym(s)
1.
saxagliptin
2.
3-hydroxyadamantylglycine-4,5-methanoprolinenitrile hydrate
3.
BMS 477118
4.
BMS-477118
5.
BMS477118
6.
Onglyza
External Link(s)
MeSHC502994
PubChem Compound11243969
BindingDB11542
50225074
ChEBI71272
CHEMBLCHEMBL385517
DrugBankDB06335
DrugCentral4114
IUPHAR/BPS Guide to PHARMACOLOGY6316
KEGGdr:D08996
Therapeutic Target DatabaseD0K9MY
Adverse Drug Event(s)
NameNumber of ReportsReference(s)Data Source
1PancreatitisFAERS: 102SIDER
US FAERS
2NauseaFAERS: 75
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
3Drug ineffectiveFAERS: 59US FAERS
4HeadacheFAERS: 52SIDER
US FAERS
5Blood glucose increasedFAERS: 46US FAERS
6DizzinessFAERS: 39OFFSIDES
SIDER
US FAERS
7Drug dose omissionFAERS: 32US FAERS
8PruritusFAERS: 28SIDER
US FAERS
9VomitingFAERS: 28
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
10Weight decreasedFAERS: 27
Canada Vigilance: 1
Canada Vigilance
US FAERS
11Abdominal PainFAERS: 23SIDER
US FAERS
12UrticariaFAERS: 22SIDER
US FAERS
13Adverse eventFAERS: 21US FAERS
14AngioedemaFAERS: 21SIDER
US FAERS
15MalaiseFAERS: 21US FAERS
16Medication ErrorFAERS: 19
Canada Vigilance: 1
Canada Vigilance
US FAERS
17Pancreatic carcinomaFAERS: 19US FAERS
18FatigueFAERS: 18SIDER
US FAERS
19Chest PainFAERS: 17OFFSIDES
US FAERS
20Abdominal discomfortFAERS: 15US FAERS
21ConstipationFAERS: 15US FAERS
22ArthralgiaFAERS: 14SIDER
US FAERS
23Urinary tract infectionFAERS: 14SIDER
US FAERS
24MyalgiaFAERS: 13SIDER
US FAERS
25SwellingFAERS: 13US FAERS
26Back PainFAERS: 12US FAERS
27Lip swellingFAERS: 12US FAERS
28NasopharyngitisFAERS: 11SIDER
US FAERS
29Blood creatinine increasedFAERS: 10OFFSIDES
SIDER
US FAERS
30Cerebrovascular accidentFAERS: 10US FAERS
31HypersensitivityFAERS: 10SIDER
US FAERS
32PalpitationsFAERS: 10US FAERS
33AstheniaFAERS: 9SIDER
US FAERS
34CholelithiasisFAERS: 9US FAERS
35PainFAERS: 9US FAERS
36Alanine Aminotransferase IncreasedFAERS: 8
Canada Vigilance: 1
Canada Vigilance
US FAERS
37AlopeciaFAERS: 8US FAERS
38Anaphylactic shockFAERS: 8SIDER
US FAERS
39Blood glucose abnormalFAERS: 8US FAERS
40Myocardial InfarctionFAERS: 8US FAERS
41OverdoseFAERS: 8US FAERS
42SomnolenceFAERS: 8US FAERS
43Wrong technique in drug usage processFAERS: 8US FAERS
44Burning sensationFAERS: 7US FAERS
45Chest discomfortFAERS: 7US FAERS
46DyspepsiaFAERS: 7
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
47Lipase increasedFAERS: 7US FAERS
48Oropharyngeal painFAERS: 7US FAERS
49TremorFAERS: 7US FAERS
50AnxietyFAERS: 6US FAERS
51Blood glucose decreasedFAERS: 6US FAERS
52ErythemaFAERS: 6US FAERS
53Feeling abnormalFAERS: 6US FAERS
54Intentional product misuseFAERS: 6US FAERS
55NervousnessFAERS: 6US FAERS
56Aspartate Aminotransferase IncreasedFAERS: 5
Canada Vigilance: 1
Canada Vigilance
US FAERS
57Atrial FibrillationFAERS: 5US FAERS
58Cardiac FlutterFAERS: 5US FAERS
59DehydrationFAERS: 5US FAERS
60Diabetes MellitusFAERS: 5US FAERS
61DysgeusiaFAERS: 5US FAERS
62SinusitisFAERS: 5SIDER
US FAERS
63Therapeutic response unexpectedFAERS: 5US FAERS
64Amylase increasedFAERS: 4US FAERS
65Angina PectorisFAERS: 4US FAERS
66BlindnessFAERS: 4US FAERS
67Cardiac ArrestFAERS: 4US FAERS
68Cerebral InfarctionFAERS: 4US FAERS
69Circumstance or information capable of leading to medication errorFAERS: 4US FAERS
70Diabetes mellitus inadequate controlFAERS: 4US FAERS
71DysphoniaFAERS: 4US FAERS
72GoutFAERS: 4US FAERS
73Medication residue presentFAERS: 4US FAERS
74PneumoniaFAERS: 4US FAERS
75PyelonephritisFAERS: 4US FAERS
76Rheumatoid ArthritisFAERS: 4US FAERS
77Skin UlcerFAERS: 4US FAERS
78Sudden deathFAERS: 4OFFSIDES
US FAERS
79Suicide attemptFAERS: 4US FAERS
80Visual ImpairmentFAERS: 4US FAERS
81Acute Coronary SyndromeFAERS: 3US FAERS
82AgitationFAERS: 3US FAERS
83AnosmiaFAERS: 3US FAERS
84ChillsFAERS: 3US FAERS
85CryingFAERS: 3US FAERS
86CystitisFAERS: 3US FAERS
87DeafnessFAERS: 3US FAERS
88DysuriaFAERS: 3US FAERS
89Ear congestionFAERS: 3US FAERS
90Erectile dysfunctionFAERS: 3SIDER
US FAERS
91FlushingFAERS: 3US FAERS
92Gamma-Glutamyltransferase IncreasedFAERS: 3US FAERS
93HypotensionFAERS: 3US FAERS
94LacerationFAERS: 3US FAERS
95Pancreatic enzymes increasedFAERS: 3US FAERS
96Pulmonary EmbolismFAERS: 3US FAERS
97Renal painFAERS: 3US FAERS
98Skin reactionFAERS: 3US FAERS
99TachycardiaFAERS: 3US FAERS
100ThrombocytopeniaFAERS: 3SIDER
US FAERS
101Urinary RetentionFAERS: 3US FAERS
102Accidental overdoseFAERS: 2US FAERS
103Acute myocardial infarctionFAERS: 2US FAERS
104AgranulocytosisFAERS: 2US FAERS
105AngerFAERS: 2US FAERS
106AscitesFAERS: 2US FAERS
107Bladder painFAERS: 2US FAERS
108Blood glucose fluctuationFAERS: 2US FAERS
109Blood urine presentFAERS: 2US FAERS
110BradycardiaFAERS: 2US FAERS
111BronchitisFAERS: 2US FAERS
112Carpal Tunnel SyndromeFAERS: 2US FAERS
113CellulitisFAERS: 2US FAERS
114Creatinine renal clearance decreasedFAERS: 2US FAERS
115DiplopiaFAERS: 2US FAERS
116DiscomfortFAERS: 2US FAERS
117Drug administration errorFAERS: 2US FAERS
118Drug prescribing errorFAERS: 2US FAERS
119Emotional disorderFAERS: 2US FAERS
120Feeling ColdFAERS: 2US FAERS
121Flank PainFAERS: 2US FAERS
122FlatulenceFAERS: 2SIDER
US FAERS
123Gastrointestinal carcinomaFAERS: 2US FAERS
124General physical health deteriorationFAERS: 2US FAERS
125HepatitisFAERS: 2US FAERS
126HungerFAERS: 2US FAERS
127InfarctionFAERS: 2US FAERS
128InfectionFAERS: 2SIDER
US FAERS
129LethargyFAERS: 2US FAERS
130LeukopeniaFAERS: 2US FAERS
131Macular degenerationFAERS: 2US FAERS
132Medication residueFAERS: 2US FAERS
133MicroalbuminuriaFAERS: 2US FAERS
134Mood swingsFAERS: 2US FAERS
135Muscle tightnessFAERS: 2US FAERS
136Musculoskeletal PainFAERS: 2US FAERS
137NephritisFAERS: 2US FAERS
138Pancreatic NeoplasmFAERS: 2US FAERS
139PregnancyFAERS: 2US FAERS
140Product quality issueFAERS: 2US FAERS
141PsoriasisFAERS: 2OFFSIDES
US FAERS
142Pulmonary congestionFAERS: 2OFFSIDES
US FAERS
143Rash erythematousFAERS: 2US FAERS
144RhabdomyolysisFAERS: 2OFFSIDES
US FAERS
145RhinitisFAERS: 2US FAERS
146Septic ShockFAERS: 2US FAERS
147Skin irritationFAERS: 2US FAERS
148Skin lesionFAERS: 2US FAERS
149SyncopeFAERS: 2US FAERS
150Therapy cessationFAERS: 2US FAERS
151Throat irritationFAERS: 2US FAERS
152TinnitusFAERS: 2US FAERS
153Transaminases increasedFAERS: 2US FAERS
154VertigoFAERS: 2US FAERS
155AbscessFAERS: 1US FAERS
156Acute kidney injuryFAERS: 1US FAERS
157AgeusiaFAERS: 1US FAERS
158Altered state of consciousnessFAERS: 1US FAERS
159AmputationFAERS: 1US FAERS
160Amyotrophic Lateral SclerosisFAERS: 1US FAERS
161Anion GapFAERS: 1US FAERS
162AnorgasmiaFAERS: 1US FAERS
163AphoniaFAERS: 1US FAERS
164ArthropathyFAERS: 1US FAERS
165AsthmaFAERS: 1US FAERS
166Benign NeoplasmFAERS: 1US FAERS
167BlepharospasmFAERS: 1US FAERS
168Blood amylase increasedFAERS: 1US FAERS
169Blood calcitonin increasedFAERS: 1US FAERS
170Blood creatine increasedFAERS: 1OFFSIDES
US FAERS
171Blood creatine phosphokinase decreasedFAERS: 1US FAERS
172Blood creatine phosphokinase increasedFAERS: 1SIDER
US FAERS
173Blood ketone body increasedFAERS: 1US FAERS
174Blood triglycerides increasedFAERS: 1SIDER
US FAERS
175Blood urea increasedFAERS: 1OFFSIDES
US FAERS
176Blue Toe SyndromeFAERS: 1US FAERS
177Brain DeathFAERS: 1US FAERS
178CachexiaFAERS: 1US FAERS
179CataractFAERS: 1US FAERS
180Cell DeathFAERS: 1US FAERS
181Cerebellar infarctionFAERS: 1US FAERS
182CholestasisFAERS: 1US FAERS
183ChromaturiaFAERS: 1US FAERS
184Completed SuicideFAERS: 1US FAERS
185Compression fractureFAERS: 1US FAERS
186Creatinine renal clearance increasedFAERS: 1US FAERS
187Cytolytic hepatitisFAERS: 1US FAERS
188Decreased immune responsivenessFAERS: 1US FAERS
189DermatitisFAERS: 1SIDER
US FAERS
190DisorientationFAERS: 1US FAERS
191Drug level increasedFAERS: 1US FAERS
192Duodenal ulcer perforationFAERS: 1US FAERS
193DysphemiaFAERS: 1US FAERS
194Ear discomfortFAERS: 1US FAERS
195Economic problemFAERS: 1US FAERS
196Ejection Fraction DecreasedFAERS: 1US FAERS
197Endometrial disorderFAERS: 1US FAERS
198EpididymitisFAERS: 1US FAERS
199EpistaxisFAERS: 1US FAERS
200EructationFAERS: 1US FAERS
201Erythema MultiformeFAERS: 1US FAERS
202Exfoliative rashFAERS: 1US FAERS
203Expired drug administeredFAERS: 1US FAERS
204Expired product administeredFAERS: 1US FAERS
205Feeling jitteryFAERS: 1US FAERS
206Fluid overloadFAERS: 1US FAERS
207Gastric infectionFAERS: 1US FAERS
208GastritisFAERS: 1SIDER
US FAERS
209Gastrointestinal PainFAERS: 1SIDER
US FAERS
210Gestational DiabetesFAERS: 1US FAERS
211Graft dysfunctionFAERS: 1US FAERS
212HemiplegiaFAERS: 1US FAERS
213Hepatitis CFAERS: 1US FAERS
214Hypertensive crisisFAERS: 1US FAERS
215IncoherentFAERS: 1US FAERS
216IncontinenceFAERS: 1US FAERS
217Incorrect dose administeredFAERS: 1US FAERS
218Insurance issueFAERS: 1US FAERS
219Intestinal ObstructionFAERS: 1US FAERS
220Intestinal infarctionFAERS: 1US FAERS
221Intraductal papillary mucinous neoplasmFAERS: 1US FAERS
222Joint stiffnessFAERS: 1US FAERS
223Joint swellingFAERS: 1US FAERS
224Low density lipoprotein increasedFAERS: 1US FAERS
225Lymphocyte count decreasedFAERS: 1US FAERS
226LymphomaFAERS: 1US FAERS
227Macular fibrosisFAERS: 1US FAERS
228Malignant ascitesFAERS: 1US FAERS
229Malignant mesenteric neoplasmFAERS: 1US FAERS
230Memory impairmentFAERS: 1US FAERS
231Metabolic acidosisFAERS: 1US FAERS
232Muscle strainFAERS: 1US FAERS
233NephrocalcinosisFAERS: 1US FAERS
234NephrolithiasisFAERS: 1US FAERS
235Nephrotic SyndromeFAERS: 1US FAERS
236NeuralgiaFAERS: 1US FAERS
237NeurodermatitisFAERS: 1US FAERS
238No adverse eventFAERS: 1US FAERS
239NocturiaFAERS: 1US FAERS
240ObesityFAERS: 1US FAERS
241OnychoclasisFAERS: 1US FAERS
242Optic nerve infarctionFAERS: 1US FAERS
243Oral painFAERS: 1US FAERS
244OverweightFAERS: 1US FAERS
245Pain of skinFAERS: 1US FAERS
246PallorFAERS: 1US FAERS
247Pancreatic PseudocystFAERS: 1US FAERS
248PancytopeniaFAERS: 1US FAERS
249Peripheral arthritisFAERS: 1US FAERS
250Peripheral swellingFAERS: 1US FAERS
251PharyngitisFAERS: 1US FAERS
252Physical deconditioningFAERS: 1US FAERS
253PneumothoraxFAERS: 1US FAERS
254PolyarthritisFAERS: 1US FAERS
255Poor peripheral circulationFAERS: 1US FAERS
256Postoperative ileusFAERS: 1US FAERS
257Precancerous mucosal lesionFAERS: 1US FAERS
258Product counterfeitFAERS: 1US FAERS
259Product dose omissionFAERS: 1US FAERS
260Product use in unapproved indicationFAERS: 1US FAERS
261Product use issueFAERS: 1US FAERS
262Renal cystFAERS: 1US FAERS
263Respiratory FailureFAERS: 1OFFSIDES
US FAERS
264Respiratory arrestFAERS: 1US FAERS
265Respiratory tract congestionFAERS: 1US FAERS
266Restless Legs SyndromeFAERS: 1US FAERS
267SciaticaFAERS: 1US FAERS
268SepsisFAERS: 1US FAERS
269Skin necrosisFAERS: 1US FAERS
270SomnambulismFAERS: 1US FAERS
271Stevens-Johnson SyndromeFAERS: 1US FAERS
272StomatitisFAERS: 1US FAERS
273StressFAERS: 1US FAERS
274Therapeutic response changedFAERS: 1US FAERS
275Thermal burnFAERS: 1US FAERS
276ThrombosisFAERS: 1US FAERS
277Toxic Epidermal NecrolysisFAERS: 1US FAERS
278Upper respiratory tract congestionFAERS: 1US FAERS
279VasculitisFAERS: 1US FAERS
280Vocal Cord ParalysisFAERS: 1US FAERS
281White blood cell count decreasedFAERS: 1US FAERS
282jaundiceFAERS: 1US FAERS
283treatment failureFAERS: 1US FAERS
284AdenocarcinomaOFFSIDES
285AlveolitisOFFSIDES
286Arteriovenous fistula site complicationOFFSIDES
287Arteriovenous fistula thrombosisOFFSIDES
288Blood uric acidOFFSIDES
289Chronic left ventricular failureOFFSIDES
290Erosive gastritisOFFSIDES
291FractureSIDER
292Gastric DilatationOFFSIDES
293GastroenteritisSIDER
294Generalized urticariaSIDER
295Inappropriate schedule of drug administrationOFFSIDES
296InfestationSIDER
297LymphopeniaSIDER
298MalnutritionSIDER
299Mental status changesOFFSIDES
300Motor Skills Disorders25446674CTD
301Muscle Rigidity25446674CTD
302Musculoskeletal discomfortSIDER
303Pericardial effusionOFFSIDES
304Polymyalgia RheumaticaOFFSIDES
305Procedural complicationOFFSIDES
306PurpuraSIDER
307QRS axis abnormalOFFSIDES
308Salmonella sepsisSIDER
309SnoringCanada Vigilance: 1Canada Vigilance
310Sudden Cardiac DeathOFFSIDES
311Thrombosis in deviceOFFSIDES
312TuberculosisSIDER
313VIIth nerve paralysisOFFSIDES
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120329

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.